OBJECTIVE: Chronic hepatitis B virus (HBV) infection can present in different ways, from inactive carrier to liver failure or cancer. The role of the virus subtype is controversial. The purpose of this study was to characterize HBV infection in detail and its impact on general health, body-build and liver biochemistry. MATERIAL AND METHODS: The study comprised a population-based cohort of Inuit exposed to HBV 3-7 decades ago in the capital in West Greenland, a coastal town and four settlements in rural East Greenland. Participants included 95% of the invited Inuit: 229 men, 205 women, aged 50-69 years. RESULTS: Only 25% of the participants had never had HBV infection. HBsAg was positive in 86 participants (20.0%), more being found positive in rural East Greenland than in the city in West Greenland (28.9% versus 2.7%; p < 0.001). HBV-DNA was positive in 61 of those with median HBV-DNA 40,000 copies/ml. HBV genotype could be determined in 52: 47 participants had genotype B, 4 genotype D, and 1 had both B and D. At sequencing, genotype B resembled subtype Bj, but with more than 5% diversity in the C-gene it could be a new subtype B. Pre-core mutation was found in 55 of 56 participants investigated. None of the participants had signs of liver disease, and HBV infection did not influence body-build or liver biochemistry. CONCLUSIONS: More than 75% of participants had a marker of present or previous HBV infection but the infection seemed dormant. The majority harbored a special variant of genotype B that might be a new subtype giving a relatively benign disease. The role of detailed subtyping of HBV for prognostic evaluation should be investigated in more detail.
OBJECTIVE:Chronic hepatitis B virus (HBV) infection can present in different ways, from inactive carrier to liver failure or cancer. The role of the virus subtype is controversial. The purpose of this study was to characterize HBV infection in detail and its impact on general health, body-build and liver biochemistry. MATERIAL AND METHODS: The study comprised a population-based cohort of Inuit exposed to HBV 3-7 decades ago in the capital in West Greenland, a coastal town and four settlements in rural East Greenland. Participants included 95% of the invited Inuit: 229 men, 205 women, aged 50-69 years. RESULTS: Only 25% of the participants had never had HBV infection. HBsAg was positive in 86 participants (20.0%), more being found positive in rural East Greenland than in the city in West Greenland (28.9% versus 2.7%; p < 0.001). HBV-DNA was positive in 61 of those with median HBV-DNA 40,000 copies/ml. HBV genotype could be determined in 52: 47 participants had genotype B, 4 genotype D, and 1 had both B and D. At sequencing, genotype B resembled subtype Bj, but with more than 5% diversity in the C-gene it could be a new subtype B. Pre-core mutation was found in 55 of 56 participants investigated. None of the participants had signs of liver disease, and HBV infection did not influence body-build or liver biochemistry. CONCLUSIONS: More than 75% of participants had a marker of present or previous HBV infection but the infection seemed dormant. The majority harbored a special variant of genotype B that might be a new subtype giving a relatively benign disease. The role of detailed subtyping of HBV for prognostic evaluation should be investigated in more detail.
Authors: Malene L Børresen; Anders Koch; Robert J Biggar; Karin Ladefoged; Mads Melbye; Jan Wohlfahrt; Tyra Grove Krause Journal: Am J Public Health Date: 2011-11-28 Impact factor: 9.308
Authors: Carla S Coffin; Scott K Fung; Fernando Alvarez; Curtis L Cooper; Karen E Doucette; Claire Fournier; Erin Kelly; Hin Hin Ko; Mang M Ma; Steven R Martin; Carla Osiowy; Alnoor Ramji; Edward Tam; Jean Pierre Villeneuve Journal: Can Liver J Date: 2018-12-25
Authors: Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn Journal: Nat Rev Gastroenterol Hepatol Date: 2020-05-28 Impact factor: 46.802
Authors: David FitzSimons; Brian McMahon; Greet Hendrickx; Alex Vorsters; Pierre Van Damme Journal: Int J Circumpolar Health Date: 2013-07-17 Impact factor: 1.228
Authors: Bo Langhoff Hønge; Sanne Jespersen; Candida Medina; David da Silva Té; Zacarias José da Silva; Sharon Lewin; Lars Østergaard; Christian Erikstrup; Christian Wejse; Alex Lund Laursen; Henrik Krarup Journal: PLoS One Date: 2014-06-10 Impact factor: 3.240